Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱(chēng) 貨號(hào) 規(guī)格
Recombinant Polynucleobacter sp. Pantothenate synthetase (panC) CSB-YP390902PYU
CSB-EP390902PYU
CSB-BP390902PYU
CSB-MP390902PYU
CSB-EP390902PYU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Polynucleobacter sp. Pyridoxine/pyridoxamine 5'-phosphate oxidase (pdxH) CSB-YP390903PYU
CSB-EP390903PYU
CSB-BP390903PYU
CSB-MP390903PYU
CSB-EP390903PYU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Polynucleobacter sp. Dihydroorotate dehydrogenase (quinone) CSB-YP390904PYU
CSB-EP390904PYU
CSB-BP390904PYU
CSB-MP390904PYU
CSB-EP390904PYU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Polynucleobacter sp. Tryptophan synthase alpha chain (trpA) CSB-YP390905PYU
CSB-EP390905PYU
CSB-BP390905PYU
CSB-MP390905PYU
CSB-EP390905PYU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Polynucleobacter sp. 50S ribosomal protein L35 (rpmI) CSB-YP390906PYU
CSB-EP390906PYU
CSB-BP390906PYU
CSB-MP390906PYU
CSB-EP390906PYU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Polynucleobacter sp. Putative NADH dehydrogenase/NAD (P)H nitroreductase Pnuc_0932 CSB-YP390907PYU
CSB-EP390907PYU
CSB-BP390907PYU
CSB-MP390907PYU
CSB-EP390907PYU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Polynucleobacter sp. Ribosomal RNA large subunit methyltransferase E (rlmE) CSB-YP390908PYU
CSB-EP390908PYU
CSB-BP390908PYU
CSB-MP390908PYU
CSB-EP390908PYU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Polynucleobacter sp. NADH-quinone oxidoreductase subunit D (nuoD) CSB-YP390909PYU
CSB-EP390909PYU
CSB-BP390909PYU
CSB-MP390909PYU
CSB-EP390909PYU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Polynucleobacter sp. Urease accessory protein UreG (ureG) CSB-YP390910PYU
CSB-EP390910PYU
CSB-BP390910PYU
CSB-MP390910PYU
CSB-EP390910PYU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Polynucleobacter sp. Urease subunit gamma (ureA) CSB-YP390911PYU
CSB-EP390911PYU
CSB-BP390911PYU
CSB-MP390911PYU
CSB-EP390911PYU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Polynucleobacter sp. Probable Fe (2+)-trafficking protein CSB-YP390912PYU
CSB-EP390912PYU
CSB-BP390912PYU
CSB-MP390912PYU
CSB-EP390912PYU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Polynucleobacter sp. 5'-nucleotidase surE (surE) CSB-YP390913PYU
CSB-EP390913PYU
CSB-BP390913PYU
CSB-MP390913PYU
CSB-EP390913PYU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Polynucleobacter sp. Ribonuclease HII (rnhB) CSB-YP390914PYU
CSB-EP390914PYU
CSB-BP390914PYU
CSB-MP390914PYU
CSB-EP390914PYU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Polynucleobacter sp. (3R)-hydroxymyristoyl-[acyl-carrier-protein] dehydratase CSB-YP390915PYU
CSB-EP390915PYU
CSB-BP390915PYU
CSB-MP390915PYU
CSB-EP390915PYU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Polynucleobacter sp. DNA ligase (ligA), partial CSB-YP390916PYU
CSB-EP390916PYU
CSB-BP390916PYU
CSB-MP390916PYU
CSB-EP390916PYU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Polynucleobacter sp. Probable potassium transport system protein kup (kup), partial CSB-YP390917PYU
CSB-EP390917PYU
CSB-BP390917PYU
CSB-MP390917PYU
CSB-EP390917PYU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Polynucleobacter sp. Lysine--tRNA ligase (lysS), partial CSB-YP390918PYU
CSB-EP390918PYU
CSB-BP390918PYU
CSB-MP390918PYU
CSB-EP390918PYU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Polynucleobacter sp. Potassium-transporting ATPase B chain (kdpB), partial CSB-YP390919PYU1
CSB-EP390919PYU1
CSB-BP390919PYU1
CSB-MP390919PYU1
CSB-EP390919PYU1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Polynucleobacter sp. Probable tRNA threonylcarbamoyladenosine biosynthesis protein Gcp (gcp) CSB-YP390920PYU
CSB-EP390920PYU
CSB-BP390920PYU
CSB-MP390920PYU
CSB-EP390920PYU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Polynucleobacter sp. Glutamine--tRNA ligase (glnS), partial CSB-YP390921PYU
CSB-EP390921PYU
CSB-BP390921PYU
CSB-MP390921PYU
CSB-EP390921PYU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過(guò)多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開(kāi)發(fā)過(guò)程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開(kāi)發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過(guò)多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過(guò)程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見(jiàn)問(wèn)題。您可以單擊以下鏈接查看。http://m.cstxtech.com/technology-91.html。此外,我們還為我們的客戶(hù)提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問(wèn),涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>